Compare TCRX & ASTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCRX | ASTC |
|---|---|---|
| Founded | 2018 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 10.5M |
| IPO Year | 2021 | 2020 |
| Metric | TCRX | ASTC |
|---|---|---|
| Price | $0.14 | $3.51 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 420.2K | 17.3K |
| Earning Date | 11-12-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.28 | ★ 2600.00 |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $10,325,000.00 | $1,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.32 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.14 | $1.92 |
| 52 Week High | $1.47 | $68.85 |
| Indicator | TCRX | ASTC |
|---|---|---|
| Relative Strength Index (RSI) | 31.39 | 26.15 |
| Support Level | N/A | $2.14 |
| Resistance Level | $0.21 | $3.76 |
| Average True Range (ATR) | 0.02 | 0.34 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 8.07 | 7.01 |
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
Astrotech Corp is a science and technology company. It creates, operates and scales businesses through its subsidiaries and technology platforms, including space-related technology, instrumentation, mass spectrometry, gas chromatography, process-control and environmental analysis technologies. It is evaluating opportunities to identify, develop and commercialize technologies with potential applications in space, defense, industrial, environmental, quantum computing, AI, semiconductor materials, lunar infrastructure and related markets. Its products include Tracer 1000 ETD, tracer 1000 NTD, Labrador HHGC, Fenceline GC, AgLab 1000-D2, among others. It operates in single segment.